The Michigan Chapter of the American Association of Clinical Endocrinologists is a professional community of physicians specializing in endocrinology, diabetes, and metabolism, committed to enhancing the ability of its members to provide the highest quality of patient care.
AACE 26th Annual Scientific and Clinical Congress 2017
For Details, Click Here.
Greater Detroit AACE Endocrine Club
We are honored to have as our guest faculty for the evening Michael Kaplan, M.D., formally of Associated Endocrinologists,
West Bloomfield, Michigan and Anca M. Avram, M.D., Associate Professor of Radiology at the University of Michigan, in Ann Arbor.
The meeting agenda will be a case-based focus pertaining to “Thyroid Cancer and Clinical Applications of the 2015 ATA Guidelines”.
Dr. Kaplan’s intense commitment to the study of thyroid pathophysiology (particularly with respect to thyroid cancer and clinically
related applications of nuclear medicine) dates to 1969 with his initial research endeavors. He has since published more than 120 journal
articles and edited four collections of text-specific review articles pertaining to various thyroid conditions.
Dr. Kaplan graduated from the University of Pennsylvania School of Medicine where he also received his endocrinology fellowship training.
He was on the faculties of Harvard Medical School and Tufts University School of Medicine before moving to Michigan in 1988 to
start full time clinical practice specializing in thyroid diseases.
Dr. Kaplan has been the recipient of the Van Meter Award of the American Thyroid Association which recognizes outstanding contributions
to research on the thyroid gland or related subjects, and the American Association of Clinical Endocrinologists’ Outstanding Clinical Endocrinologist Award.
Dr. Avram currently serves as Director of the Nuclear Medicine Therapy Program. After she received her medical degree, Dr. Avram pursued
initial post-graduate training in Internal Medicine, and then completed two fellowships at the University of Michigan: one in Endocrinology,
Metabolism and Diabetes, and the other in Nuclear Medicine. In 2005, Dr. Avram joined the faculty of the University of Michigan specializing
in nuclear medicine and radionuclide therapies. Since that time, she has been a contributing author on 48 peer-reviewed scientific manuscripts,
48 abstract presentations at national meetings and 8 book chapters. Dr. Avram’s clinical interests include radioactive iodine treatment for hyperthyroidism,
thyroid cancer and radioimmunotherapy for lymphoma. Her research interests focus on the role of diagnostic radioiodine imaging for guiding
131-I treatment for thyroid cancer, and clinical dosimetry protocols for metastatic thyroid cancer. Building on a solid clinical foundation, Dr. Avram
continues a vibrant clinical research program at the University of Michigan with NIH-funded research in radio-immunotherapy in addition to
research in thyroid cancer imaging-based staging, patient risk stratification prior to radioiodine therapy and tumor dosimetry.
Dr. Avram is certified by the American Board of Internal Medicine, the American Board of Endocrinology & Metabolism, and the American
Board of Nuclear Medicine. She is a member of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Endocrine Society.
Similar to past venues, the evening will undoubtedly prove to be both clinically and didactically fascinating.
As always, we continue to encourage all participating attendees to bring unique case conundrums for presentation and collegial discourse.
Representatives of Sanofi-Genzyme Pharmaceuticals will be joining us for the evening as they have graciously agreed to exhibit
at and support this program.
If you plan to attend, please reply via e-mail to Ilene Rappoport (firstname.lastname@example.org) with your name, and phone number